Clinical Trial Update: Bioavailability of Ubiquinol in Huntington Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluated the bioavailability of ubiquinol in individuals with Huntington's disease and is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Ubiquinol (ubiquinol)

Snippet

Sponsor: University of Rochester | Conditions: Huntington Disease | Phase 1 | Status: COMPLETED